LDL SIZE DETERMINANTS DURING ANTIRETROVIRAL THERAPY INCLUDING PROTEASE INHIBITORS IN HIV-1 INFECTED PATIENTS

被引：0
|
作者：
Bittar, R. [1 ]
机构：
[1] Assistance Publ Hop Paris, Grp Hosp Pitie Salpetriere, Serv Biochim Metab, Unite Fonctionnelle Biochim Malad Metab, Paris, France
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2011年 / 12卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(11)70126-X
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
125
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [31] Antiretroviral therapy in patients infected with HIV-1.
    Corti, ME
    MEDICINA-BUENOS AIRES, 1998, 58 : 49 - 56
  • [32] Persistent HIV-1 replication during antiretroviral therapy
    Martinez-Picado, Javier
    Deeks, Steven G.
    CURRENT OPINION IN HIV AND AIDS, 2016, 11 (04) : 417 - 423
  • [33] Genotypic Determination of HIV Tropism in a Cohort of Patients Perinatally Infected With HIV-1 and Exposed to Antiretroviral Therapy
    Di Biagio, Antonio
    Parisini, Andrea
    Bruzzone, Bianca
    Prinapori, Roberta
    Lauriola, Marinella
    Paolucci, Stefania
    Signori, Alessio
    Barresi, Renata
    Icardi, Giancarlo
    Calderisi, Silvia
    Meini, Genny
    Dentone, Chiara
    Cenderello, Giovanni
    Guerra, Michele
    Maccabruni, Anna
    Rusconi, Stefano
    Viscoli, Claudio
    HIV CLINICAL TRIALS, 2014, 15 (01): : 45 - 49
  • [34] Protease gene polymorphism in HIV-1-infected patients and response to therapy including a protease inhibitor.
    Mouroux, M
    Bossi, P
    Yvon-Groussin, A
    Delaugerre, C
    Valantin, MA
    Tubiana, R
    Coutellier, A
    Bonmarchand, M
    Bricaire, F
    Katlama, C
    Agut, H
    Huraux, JM
    Calvez, V
    PATHOLOGIE BIOLOGIE, 1999, 47 (05): : 549 - 552
  • [35] Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors
    Sacktor, NC
    Skolasky, RL
    Lyles, RH
    Esposito, D
    Selnes, OA
    McArthur, JC
    JOURNAL OF NEUROVIROLOGY, 2000, 6 (01) : 84 - 88
  • [36] Combination antiretroviral therapy including protease inhibitors improves psychomotor speed performance in HIV infection
    Sacktor, N
    Skolasky, R
    Esposito, D
    Lyles, R
    McFarlane, G
    Nance-Sproson, T
    Selnes, O
    McArthur, J
    NEUROLOGY, 1998, 50 (04) : A248 - A249
  • [37] The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients
    Chang, ES
    Tetreault, DD
    Liu, YT
    Beall, GN
    JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2001, 101 (06) : 687 - 689
  • [38] The effects of antiretroviral treatment with protease inhibitors (PIS) on serum lipids in HIV infected patients
    Chrysos, G
    Mangafas, N
    Bilianou, H
    Paraskeva, D
    Kamaratos, A
    Antonopoulos, S
    Giannacopoulos, D
    Lazanas, MK
    ATHEROSCLEROSIS, 1999, 144 : 122 - 122
  • [39] The influence of protease inhibitors on a frequency of lipid metabolism disturbances occurrence in HIV-1 infected patients
    Jaroszewicz, Jerzy
    Wiercinska-Drapalo, Alicja
    Prokopowicz, Danuta
    HIV & AIDS REVIEW, 2007, 6 (02): : 19 - 23
  • [40] HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy
    Balcom, E. F.
    Roda, W. C.
    Cohen, E. A.
    Lie, M. Y.
    Power, C.
    CURRENT OPINION IN VIROLOGY, 2019, 38 : 54 - 62
12345